Shares of Centene (NYSE:CNC) lost ~10% in the early premarket trading on Friday after the Medicaid-driven managed care firm ...

Analysts have given Centene a total of 16 ratings, with the consensus rating being Neutral. The average one-year price target is $49.62, indicating a potential 68.66% upside.

Centene stock tumbled after reporting a surprise Q2 loss, driven by rising medical costs and a weak outlook, shaking ...

Centene’s stock pulled a sharp U-turn into the green, after the health insurer helped assuage investor worries by providing ...

Centene reported a $253 million loss in its second quarter as the provider of government-subsidized health benefits struggles ...

Centene Corporation ( NYSE: CNC) Q2 2025 Earnings Conference Call July 25, 2025 8:30 AM ET a - Corporate Participant v - Corporate Participant Andrew Lynn Asher - Chief Financial Officer Jennifer ...

The California-based insurer outlined its plans to survive what CEO Joe Zubretsky deemed a “season of great uncertainty” ...

Centene raised its adjusted EPS guidance by $0.15 to at least $6.60 (or at least 14% growth) and kept intact its 2024 EPS guidance floor of at least $6.60, which looks likely to be constrained by ...

Centene's latest analysis results in a reduction to its previous full-year net risk adjustment revenue transfer expectation of about $1.8 billion, which corresponds to a drop in earnings.

Centene Backs Annual Earnings Outlook Above View, Initiates 2025 Guidance December 12, 2024 — 06:43 am EST Written by RTTNews.com for RTTNews -> ...

Also, Centene increased its adjusted EPS guidance to at least $6.40 (or at least 11% growth) from a range of $6.25 to $6.40 previously, which is mildly higher than our previous expectation.